Navigation Links
Coalition for Pulmonary Fibrosis Celebrates Landmark Year for Awareness, Advocacy, Research
Date:12/31/2008

SAN JOSE, Calif. Dec. 31 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) calls 2008 a year of substantial progress in advocacy, research support and awareness of a fatal disease that has no known cause, no FDA-approved treatment, and no cure - Pulmonary Fibrosis (PF).

The CPF was able to double its research grant funding through a partnership with the American Thoracic Society (ATS). The CPF/ATS partnership enables the search for treatments to assist patients who are suffering from this relentless and ultimately fatal disease. As many as 40,000 patients die each year to PF - the same number as are lost to breast cancer.

The organization drove a national advocacy effort leading to the introduction of the Pulmonary Fibrosis Research Enhancement Act (PFREA), and greatly enhanced its resources via expanded Internet campaigns, a fully redesigned website (http://www.coalitionforpf.org) and the publication of comprehensive, peer-reviewed patient education materials.

The landmark PFREA was introduced on July 23, 2008 in the U.S. House of Representatives by Rep. Brian Baird (D-WA) and Rep. Mike Castle (R-DE). The PFREA is the first legislation specifically seeking congressional funding for PF research, and would authorize $16 million to create a comprehensive national registry to help in understanding the cause and progression of the disease, which in turn would allow for improved standards of care and accelerated research. The bill also carries provisions to improve public awareness of PF and creates a National PF Advisory Board.

Rep. Baird lost his father to PF, and Rep. Castle lost his brother and sister to the devastating disease. The bill is expected to be reintroduced in the House early in 2009 and soon after in the Senate.

"We are very excited about the potential for congressional support whi
'/>"/>

SOURCE Coalition for Pulmonary Fibrosis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
2. Coalition America Announces Addition of Mollie Gordon Brown as Chief Strategy Officer
3. Health IT Now! Coalition to Discuss the Urgent Need to Pass Health IT Legislation
4. Health IT Now! Coalition Urges Congress to Pass Health Information Technology Bill This Year
5. Fairness Coalition Applauds Senate Passage of Mental Health Parity Bill
6. Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators
7. Health IT Now! Coalition Calls on Congress to Pass Health Information Technology Legislation This Year
8. Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access
9. Hospital-led Coalition Cautions Motorists on New Risks October 1, Lauds Legislative Leaders for Scheduling No-fault Hearings Next Week
10. Coalition to Protect Floridas Drivers Applauds Governor Crist for Adding PIP to Special Session
11. Hospitals and the Coalition to Protect Floridas Drivers Applaud Lawmakers for Reviving No-Fault Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Study suggests blood test can help improve treatment outcomes for breast cancer patients 2Health News:CoorsTek Holds Grand Opening for Newest Facility in South Korea 2Health News:CoorsTek Holds Grand Opening for Newest Facility in South Korea 3Health News:Don't Wait for the Election to Plan Your Long-Term Healthcare, Insurance Leader Advises 2Health News:Chemo for Mesothelioma Offers Limited Survival Benefits 2Health News:dLife Launches the World's Largest and Most Comprehensive Online Food and Diabetic Recipe Search Tool 2Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 2Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 3Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 4Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 5Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 6Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 7Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 8
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Express Scripts Launches Equity Offering to Finance Acquisition 47588 1Express Scripts Launches Equity Offering to Finance Acquisition 47588 2Express Scripts Launches Equity Offering to Finance Acquisition 47588 3Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 1Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 2Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 3Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 4Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 5Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 1Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 2Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 3
Other Medicine Technology:Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 2Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 3Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 4Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 5